Details of the Drug
General Information of Drug (ID: DM3OBQF)
Drug Name |
Belimumab
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | Belimumab (USAN); LymphoStat-B; LymphoStat-B (TN) | ||||||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||||||
Drug Type |
Antibody
|
||||||||||||||||||||||||||
ADMET Property |
|
||||||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||||||
Repurposed Drugs (RPD) | Click to Jump to the Detailed RPD Information of This Drug | ||||||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Drug-Drug Interaction (DDI) Information of This Drug
Coadministration of a Drug Treating the Disease Different from Belimumab (Comorbidity)
|
References